#China, The dominant circulating #strain is the sixth-generation #subvariant #NB181 of the #XDV variant, which has not shown any significant changes in pathogenicity or clinical severity. GT: www.globaltimes.cn/page/202505/...
Here's the latest variant picture for Europe (excluding the UK), to early May.
The LP.8.1.* variant continued to dominate, growing steadily to around 52% frequency.
#COVID19 #EUR #LP_8_1 #XFG #XDV #NB_1_8_1 #XFJ
🧵
Here's the latest variant picture for the United States, to early May.
The LP.8.1.* variant has peaked and fell back to 52%.
The presumed next challengers are growing – XDV.* (led by NB.1.8.1) to 9% and XFG.* to 8%.
#COVID19 #USA #LP_8_1 #XFG #XDV #NB_1_8_1
🧵
Here's the latest variant picture for New Zealand, to mid-May.
DeFLuQE variants continue to dominate at around 40-55%, but finally look under threat.
The XDV.* variant clan (driven by NB.1.8.1) grew to around 24%.
#COVID19 #NZ #DeFLuQE #XDV #NB_1_8_1
🧵
Here's the latest variant picture for Australia, to early May.
XEC.* has been dominant, but declined to around 32%.
LP.8.1.* has grown to 23%, and XDV.* (driven by NB.1.8.1) grew to 18%.
#COVID19 #Australia #XEC # LP_8_1 #NB_1_8_1 #XDV
🧵
Here's the latest variant picture with a global scope, to early May.
The dominant LP.8.1.* variant has fallen to around 34%.
XDV.* (led by NB.1.8.1) is challenging, rising steadily to 18%
#COVID19 #Global #LP_8_1 #XDV #NB_1_8_1
🧵
Neue #Corona -Welle in asiatischen Ländern www.stuttgarter-nachrichten.de/inhalt.coron...
Ein führender Experte für Atemwegserkrankungen in China, Zhong Nanshan, warnte demnach jedoch vor Panik. Der aktuelle Erregerstamm #XDV sei zwar hoch ansteckend, der Erkrankungsgrad jedoch relativ gering
Here's the latest variant picture for Europe (excluding the UK), to mid-April.
The LP.8.1.* variant took over dominance, growing steadily to around 43% frequency.
#COVID19 #EUR #LP_8_1 #XFG #XDV #NB_1_8_1 #XFJ
🧵
Here's the latest variant picture for the United States, to late April.
The LP.8.1.* variant appears to have peaked and fell back to 54%.
#COVID19 #USA #LP_8_1 #XFG #XDV
🧵
Here's the latest variant picture for Australia, to mid-April.
XEC.* continues to dominate, but declined further to around 30%.
The next challenger now looks like LP.8.1.*, growing a bit faster to around 27%
#COVID19 #Australia #XEC # LP_8_1 #NB_1_8_1 #XDV
🧵
Here's the latest variant picture with a global scope, to late April.
Growth of the LP.8.1.* variant is holding at around 39%.
XDV.* (led by NB.1.8.1) looks like the next challenger, rising steadily to 13%
#COVID19 #Global #LP_8_1 #XDV #NB_1_8_1
🧵
Here's the latest variant picture for the United States, to mid-April.
The LP.8.1.* variant growth continued to around 61%, but may have peaked.
The presumed next challengers – XFG.* and XDV.* (led by NB.1.8.1) are still below 5%.
#COVID19 #USA #LP_8_1 #XFG #XDV
🧵
Here's the latest variant picture for Australia, to mid-April.
XEC.* continues to dominate, but declined quite sharply into around 40%.
The next challenger looks is XDV.*, driven by it’s latest sub-lineage NB.1.8.1, rising to 11%.
#COVID19 #Australia #XEC #NB_1_8_1 #XDV
🧵